CONGRESS OF THE EUROPEAN COLLEGE OF VETERINARY INTERNAL MEDICINE - COMPANION ANIMALS

Orals

ESVIM – European Society of Veterinary Internal Medicine 
Thursday 14 September
09.00-09.15 ESVIM-O-1 Cuq Calibrated automated thrombography to evaluate thrombin generation in dogs with immune-mediated hemolytic anaemia
09.15-09.30 ESVIM-O-2 Dandrieux Effect of immune-suppressive treatment on cytokine production in healthy dogs
09.30-09.45 ESVIM-O-3 Hansson-Hamlin Identification of antinuclear antibodies in dogs using immunodiffusion
Friday 15 September
14.40-14.55 ESVIM-O-4 Brown Short- and long-term morbidity and mortality in dogs and cats following cardiopulmonary arrest
14.55-15.10 ESVIM-O-6 Darcy Feline primary erythrocytosis: a multicentre retrospective case series (18 cases)
15.10-15.25 ESVIM-O-7 Roels Investigation of a fungal aetiology in canine idiopathic pulmonary fibrosis
15.25-15.40 ESVIM-O-8 Keegan Clinical features of 70 cases of canine idiopathic eosinophilic lung disease
15.40-15.55 ESVIM-O-9 Keegan Therapy and long-term follow-up of 70 cases of canine idiopathic eosinophilic lung disease
16.30-16.45 ESVIM-O-10 Vientos-Plotts Development of respiratory dysbiosis as cats transition from healthy to asthmatic airways
16.45-17.00 ESVIM-O-11 Grobman Documenting silent reflux and microaspiration events using nuclear scintigraphy in healthy dogs
17.00-17.15 ESVIM-O-12 Canonne Diagnosis of pulmonary angiostrongylosis in dogs with negative non-invasive tests (Baermann analysis and AngioDetectTM©)
17.15-17.30 ESVIM-O-13 Grobman Discrimination between cough and non-cough behaviours using acoustic wave recordings
17.30-17.45 ESVIM-O-14 Robin Tracheal stent in dogs: outcome prediction and owner satisfaction assessment
17.45-18.00 ESVIM-O-15 Stengel Meticulous debridement as sole management for successful outcome in 6 dogs with sinonasal aspergillosis (SNA)
ESVC – European Society of Veterinary Cardiology
Thursday 14 September
14.25-14.40 ESVC-O-1 Vitt Utility of VHS to predict echocardiographic EPIC Trial inclusion criteria in dogs with myxomatous mitral valve disease: A retrospective multicentre study
14.40-14.55 ESVC-O-2 Rocchi Evaluation of continuous positive airway pressure in dogs with cardiogenic pulmonary oedema secondary to severe mitral valve disease
14.55-15.10 ESVC-O-3 Rishniw Development of a simple algorithm for diagnosis of left-sided congestive heart failure in dogs with mitral valve disease
15.10-15.25 ESVC-O-4 Lee Effects of treatment with thromboxane A2 synthase inhibitor on pulmonary hypertension: a pilot study
15.25-15.40 ESVC-O-5 Vezzosi Echocardiographic evaluation of right ventricular dimension and systolic function in dogs with pulmonary hypertension
15.40-15.55 ESVC-O-6 Merveille Caudal vena cava assessment in dogs with right-sided congestive heart failure: a pilot study
15.55-16.10 ESVC-O-7 Blake Heart rate variability in dogs with intracranial disease
16.10-16.25 ESVC-O-8 Kiss Genetic background of focal junctional tachycardia with isorhythmic atrioventricular dissociation in Labrador retrievers
16.25-16.40 ESVC-O-9 Oxford Immunofluorescent localization of plakoglobin in endomyocardial biopsy samples to diagnose arrhythmogenic right ventricular cardiomyopathy (ARVC) in the dog
Friday 15 September
08.00-08.15  ESVC-O-10 LeBlanc Right ventricular volume quantification measured by real-time 3D echocardiography and ECG-gated 64 slice MDCT in healthy dogs
08.15-08.30 ESVC-O-11 Damoiseaux Feasibility of intracardiac echocardiography in dogs: a pilot study
08.30-08.45 ESVC-O-12 Corda Use of two-dimensional speckle tracking echocardiography to assess left ventricular systolic function in dogs with systemic inflammatory response syndrome
08.45-09.00 ESVC-O-13 Bree Major histocompatibility complex class II haplotypes associated with remodelling in Cavalier King Charles spaniels with chronic valvular heart disease
11.20-11.35


 
ESVC-O-14 Traub MiRNAs in progressing canine myxomatous mitral valve disease
11.35-11.50  ESVC-O-15 Tims White coat effect in client-owned dogs, as assessed by high definition oscillometry (HDO)
11.50-12.05  ESVC-O-16 Mckeever Prevalence and murmur characteristics of incidentally detected heart murmurs and heart disease in 12,958 young healthy shelter cats
12.05-12.20


 
ESVC-O-17 Szatmári When should we talk about tachypnoea in cats at the veterinarian’s consultation room?
12.20-12.35  ESVC-O-18 Szatmári How often do primary care practitioners recognise innocent cardiac murmurs in puppies during the first veterinary health check?
12.35-12.50  ESVC-O-19 Connolly Towards cardiac stem cell therapy: characterisation and cryopreservation of canine cardiosphere-derived cells
16.45-17.00 ESVC-O-20 Dutton Assessing the feasibility of allogeneic stem cell therapy for canine dilated cardiomyopathy
17.00-17.15 ESVC-O-21 Ohad The association of clinical, laboratory and echocardiographic findings with survival in 108 dogs undergoing pericardiocentesis; a retrospective study
17.15-17.30
 
 
ESVC-O-22 Neves Usefulness of colour TDI at the level of lateral atrial tissue as a predictor of future development of atrial fibrillation in dogs
17.30-17.45 ESVC-O-23 Beijerink ECG-gated computed tomography angiography of patent ductus arteriosus in 25 dogs
17.45-18.00 ESVC-O-24 Szatmári Is prophylactic antibiotic therapy necessary to prevent infectious endocarditis in dogs that undergo transcatheter embolisation of a patent ductus arteriosus?
Saturday 16 September
16.30-16.45
 
 
ESVC-O-25 Gomart Biological variability of N-terminal pro-B-type natriuretic peptide in fifty-three healthy Labrador retrievers over an 8 month period
16.45-17.00 ESVC-O-26 Glen Clinical use of a patient-side feline NT-proBNP ELISA test in 281 cats in general practice
17.00-17.15 ESVC-O-27 Romito Diagnostic and prognostic utility of surface ECG in cats with left ventricular hypertrophy
17.15-17.30 ESVC-O-28 Winter Notched QRS complexes in dogs with and without structural cardiac disease: 85 cases
ESVNU – European Society of Veterinary Nephrology and Urology
Thursday 14 September
14.25-14.40 ESVNU-O-1 Sargent Fibroblast growth factor 23 and symmetric dimethylarginine in feline chronic kidney disease
14.40-14.55 ESVNU-O-2 van den Broek Immunohistochemical staining of a-klotho protein in feline kidney tissue
14.55-15.10 ESVNU-O-3 Pelander Symmetric dimethylarginine (SDMA) compared to creatinine for detection of decreased GFR in 97 dogs with stable kidney function
15.10-15.25 ESVNU-O-4 Buresova SDMA in hyperthyroid cats before and after treatment with radioiodine
15.25-15.40 ESVNU-O-5 Chen Interleukin 6 and Interleukin 18 as markers of kidney injury in dogs
15.40-15.55 ESVNU-O-6 Segev Application of novel kidney-specific biomarkers for canine kidney diseases
15.55-16.10 ESVNU-O-7 Lamoureux Prevalence of urinary tract infection in dogs with chronic kidney disease: a retrospective study of 201 cases
16.10-16.25 ESVNU-O-8 Johnstone Whole genome sequencing of Escherichia coli isolated from the urinary tract of individual dogs over time
16.25-16.40 ESVNU-O-9 Pomba Virulence and antimicrobial resistance of Escherichia coli Sequence Type 131 H30 and other human pandemic clones spreading in companion animals
Saturday 16 September
14.25-14.40 ESVNU-O-10 Russak Urinary biomarker concentrations in canine urinary tract infections
14.40-14.55 ESVNU-O-11 Garcia Evolution of ionised calcium concentration over time in cats with ureteral obstruction: 39 cases
14.55-15.10 ESVNU-O-12 Crisi Urinary findings suggesting early renal involvement in cats with Feline Morbillivirus infection
15.10-15.25 ESVNU-O-13 Reynolds Effects of a non-absorbent litter on urinalysis results in cats
15.25-15.40 ESVNU-O-14 Garcia Determining the pH in canine urine: comparing visual and automated reading variability of urine dipstick analysis within a small animal teaching hospital
15.40-15.55 ESVNU-O-15 van den Berg Assessment of kidney injury in canine parvoviral infection by comparing novel urinary kidney injury biomarkers with routine renal functional parameters
ESVONC – European Society of Veterinary Oncology
Friday 15 September
09.30-09.45 ESVONC-O-1 Zandvliet Are protein kinase inhibitors of use in the treatment of canine lymphoma? A screening in vitro study with multiple protein kinase inhibitors in canine lymphoid cell lines
09.45-10.00 ESVONC-O-2 Giuliano Masitinib treatment for advanced stage III and IV canine melanoma
10.00-10.15 ESVONC-O-3 Elliott Toceranib phosphate in fifteen dogs with stage 4 anal sac apocrine gland adenocarcinoma
10.15-10.30 ESVONC-O-4 Lyons Effect of toceranib phosphate (Palladia®) on outcome in dogs with anal sac carcinoma
11.20-11.35


 
ESVONC-O-5 Børresen The occurrence of feline neoplasia; a comparison between Danish and North American cats
11.35-11.50  ESVONC-O-6 Aghazadeh Expression of Felis catus gammaherpesvirus-1 ORF73, F7 and ORF50 in FIV-associated lymphoma biopsies
11.50-12.05  ESVONC-O-7 Boye High pretreatment D-dimer concentraion is associated with poor prognosis in 48 dogs with high-grade lymphoma
12.05-12.20

 
ESVONC-O-8 Treggiari Efficacy of chemotherapy and clinical outcome in primary, metastatic feline pulmonary carcinomas: an observational study
12.20-12.35 ESVONC-O-9 Aupperle-Lellbach Ovarian tumours in the bitch – Pathological findings and AMH values
12.35-12.50 ESVONC-O-10 Bechtel Initial evaluation of gum arabic coated radioactive gold nanoparticles in canine prostatic cancer
SCH – Society of Comparative Hepatology 
Friday 15 September
08.00-08.15 SCH-O-1 Bayton Prednisolone therapy for chronic hepatitis in the English Springer Spaniel: A prospective study of 14 cases
08.15-08.30 SCH-O-2 Ullal Ciclosporin in the treatment of canine chronic hepatitis
08.30-08.45 SCH-O-3 Kortum Investigation into hepatocyte expression and prognostic significance of senescence marker p21 in canine chronic hepatitis
08.45-09.00 SCH-O-4 Sato Chronic portal vein thrombosis in eleven dogs
09.00-09.15 SCH-O-5 Allerton Breed predisposition to gall bladder mucocoeles in Border Terriers
09.15-09.30 SCH-O-6 Valiente Outcome of cats undergoing surgical attenuation of congenital extrahepatic portosystemic shunts through cellophane banding: 23 cases
09.30-09.45 SCH-O-7 Neiger Transcutaneous fluorometric measurement of indocyanine green clearance as dynamic liver function test in dogs with congenital portosystemic shunt
ESCG – European Society of Comparative Gastroenterology
Friday 15 September
09.45-10.00 ESCG-O-1 Heilmann Serum S100/calgranulin concentrations in Miniature Schnauzers with idiopathic hyperlipidemia
10.00-10.15 ESCG-O-2 Williams Serum tocopherol and retinol concentrations in dogs with exocrine pancreatic insufficiency
10.15-10.30 ESCG-O-3 Schleifenbaum Effect of mirtazapine on canine gastric emptying assessed by 13C-sodium acetate breath test (13C-SABT)
11-20-11.35 ESCG-O-4 Botha Prevalence of Clostridium difficile and Salmonella spp. in Juvenile Dogs Affected with Parvoviral Enteritis
11.35-11.50 ESCG-O-5 Albuquerque Risk factors for C. difficile carriage in dogs and associations with clinical disease
11.50-12.05 ESCG-O-6 Manchester Long-term impact of tylosin on the faecal microbiota of healthy dogs
12.05-12.20 ESCG-O-7 Cartwright Vitamin D receptor expression in the dog and the effect of intestinal inflammation
12.20-12.35 ESCG-O-8 Konstantinidis Serum circulating microRNAs as a marker for canine lymphocytic- plasmacytic inflammatory bowel disease
12.35-12.50 ESCG-O-9 Allenspach Specific virulence factors in mucosa-associated E. coli of dogs with inflammatory bowel disease (IBD) are associated with survival
Saturday 16 September
16.30-16.45 ESCG-O-10 Coddou Identification of IgG4-related disease in the English Cocker Spaniel and dogs of other breeds
16.45-17.00 ESCG-O-11 Allenspach Correlating gastrointestinal histopathologic findings to clinical disease activity in dogs with inflammatory bowel disease
17.00-17.15 ESCG-O-12 Freiche Acquired oesophageal strictures: balloon dilatation or stenting? Outcome and complications in 24 dogs and cats (2002-2017)
17.15-17.30 ESCG-O-13 Dominguez Ruiz Prevalence of gastric lymphoid follicular hyperplasia in French Bulldogs
17.30-17.45  ESCG-O-14 Woolhead A retrospective evaluation of ileocecocolic perforations associated with routine diagnostic lower gastrointestinal endoscopy in dogs and cats
17.45-18.00  ESCG-O-15 Da Riz Acquired pyloric stenosis in cats: a prospective study of 15 cats (2015-2017)
ESVE – European Society of Veterinary Endocrinology
Saturday 16 September
08.15-08.30 ESVE-O-1 Sieber-Ruckstuhl Agreement of two prepill cortisol measurements in dogs with hypercortisolism treated with trilostane
08.30-08.45 ESVE-O-2 van Staalduinen Sterol-O-acyl transferase 1 (SOAT1) expression in canine cortisol-secreting adrenocortical tumours: providing the basis for a future treatment option
08.45-09.00 ESVE-O-3 de Wit CYP17 inhibitor abiraterone acetate as a promising future treatment for canine hyperadenocorticism: in vitro investigations
14.25-14.40 ESVE-O-4 Sanders Molecular prognostic markers in canine cortisol-secreting adrenocortical tumours
14.40-14.55 ESVE-O-5 Hanson The use of chromogranin A epitopes vasostatin and catestatin as biomarkers for catecholamine-producing tumours in dogs
14.55-15.10 ESVE-O-6 Scudder Pilot study assessing the use of cabergoline in the management of diabetic acromegalic cats
15.10-15.25 ESVE-O-7 Woolhead Serial changes in insulin-like growth factor 1 and impact on hypersomatotropism-screening in feline diabetes mellitus
15.25-15.40 ESVE-O-8 Zini Ultrastructural characterisation of pancreatic beta-cells in cats with diabetes mellitus
15.40-15.55 ESVE-O-9 Niessen The diabetic clinical score (DCS): evaluation of a simple standardised quantification tool to allow rapid description of clinical signs in diabetic dogs
16.30-16.45 ESVE-O-10 Finch Thyroid and renal function in cats post low-dose radioiodine therapy
16.45-17.00 ESVE-O-11 Casado Diaz Evaluation of symmetric dimethylarginine (SDMA) in dogs with primary hypoadrenocorticism under long-term mineralocorticoid replacement therapy
17.00-17.15 ESVE-O-12 Spence A comparison of the ACTH concentrations in dogs with stable hypoadrenocorticism being treated with either fludrocortisone or desoxycortone pivalate and prednisolone
17.15-17.30 ESVE-O-13 Hagblom Prevalence of hyperaldosteronism and hypertension in cats with chronic azotaemia
17.30-17.45 ESVE-O-14 Pijnacker The use of a TRH stimulation test, with measurement of plasma concentrations of growth hormone and thyroid stimulating hormone, to differentiate between primary hypothyroidism and non-thyroidal illness in dogs
17.45-18.00 ESVE-O-15 Scarpa Interrelation between thyroid function and sex hormones in female German Shepherd Dogs
ESVCN – European Society of Veterinary Comparative Nutrition
Saturday 16 September
08.15-08.30 ESVCN-O-1 Söder Plasma metabolomics reveals lowered carnitine concentrations in overweight Labrador retriever dogs
08.30-08.45 ESVCN-O-2 Kiefer-Hecker Silica urolithiasis in a dog - a case report
08.45-09.00 ESVCN-O-3 Dobenecker Knowing the total amount of phosphorus in a diet is not enough – different sources have different effects
ESVCP – European Society of Veterinary Clinical Pathology
Saturday 16 September
09.15-09.30 ESVCP-O-1 Aroch Pre- and post-operative D-dimer concentration in dogs changes in D-dimer concentration in dogs following soft tissue and orthopaedic surgery
09.30-09.45 ESVCP-O-2 Whitehead Evaluation of haemostatic changes in dogs with parvoviral enteritis before and after fluid resuscitation using thromboelastography
09.45-10.00 ESVCP-O-3 König Analytical and clinical validation of a human enzyme-linked immunosorbent assay (ELISA) for measurement of canine angiopoietin-2
10.00-10.15 ESVCP-O-4 König Plasma angiopoietin-2 (Ang-2) is elevated in dogs with sepsis and/or systemic inflammatory disease syndrome (SIRS) and is associated with severity of disease and outcome
10.15-10.30 ESVCP-O-5 Neumann Investigation of Interleukin-6 (IL-6) as prognostic marker
11.20-11.35 ESVCP-O-6 Leynaud Comparison of serum amyloid A and fibrinogen to other inflammatory biomarkers in cats
11.35-11.50 ESVCP-O-7 Bremer Identification of ILF2 autoantibodies as a promising biomarker for autoimmune disease in dogs
11.50-12.05 ESVCP-O-8 Aroch Serum histones as biomarkers of the severity of heatstroke in dogs
12.05-12.20 ESVCP-O-9 Zoia Pleural effusion lactate dehydrogenase (LDHp) concentration and serum total protein (TPs) concentration versus traditional veterinary classification method in the discrimination between transudates and exudates: a cross-sectional study in 100 dogs with pleural effusion
12.20-12.35 ESVCP-O-10 Burchell The site of bone marrow acquisition affects the myeloid to erythroid ratio in apparently healthy dogs
12.35-12.50 ESVCP-O-11 Cuq Acute myeloid leukemia in retrovirus-negative cats: a case series of 16 patients
ISCAID - International Society for Companion Animal Infectious Diseases
Saturday 16 September
11.20-11.35 ISCAID-O-1 Barrs Re-emergence of feline panleukopenia in Australia
11.35-11.50 ISCAID-O-2 Byrne Investigation of faecal parvovirus shedding in asymptomatic shelter housed cats in Australia
11.50-12.05 ISCAID-O-3 Ferri Class A CpG oligonucleotides in cats with naturally occurring feline panleukopenia infection: a prospective case-control study
12.05-12.20 ISCAID-O-4 Barrs Feral carnivores are reservoirs of Carnivore protoparvovirus 1 in Australia
12.20-12.35 ISCAID-O-5 de Luca Feline morbillivirus infection in domestic cats in Italy: epidemiological and pathological aspects
12.35-12.50 ISCAID-O-6 Felten Evaluation of a discriminative realtime RT-PCR in cerebrospinal fluid for the diagnosis of feline infectious peritonitis
14.25-14.40 ISCAID-O-7 Duplan Screening for selected pathogens in ticks infecting cats in the United Kingdom: a large-scale surveillance programme
14.40-14.55 ISCAID-O-8 Dvir The role of hypovitaminosis d in complicated canine babesiosis
14.55-15.10 ISCAID-O-9 Barash Is urine culture the poor man’s blood culture? Concordance between parallel canine blood and urine cultures
15.10-15.25 ISCAID-O-10 Pomba Companion animals and humans with UTI share common uropathogenic Klebsiella pneumoniae
15.25-15.40 ISCAID-O-11 Leutenegger Validation of a qPCR panel to aid in the diagnosis of dermatophytosis
VBPS - Veterinary Blood Pressure Society   
16.30-16.45 VBPS-O-1 Glaus Efficacy of telmisartan in hypertensive cats: results of a large European clinical trial